<VariationArchive VariationID="631958" VariationName="NM_022464.5(SIL1):c.947dup (p.Arg317fs)" VariationType="Duplication" Accession="VCV000631958" Version="15" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-03-17" DateCreated="2019-05-27" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="620186" VariationID="631958">
      <GeneList>
        <Gene Symbol="SIL1" FullName="SIL1 nucleotide exchange factor" GeneID="64374" HGNC_ID="HGNC:24624" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>5q31.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="138946724" stop="139198368" display_start="138946724" display_stop="139198368" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="138282408" stop="138534064" display_start="138282408" display_stop="138534064" Strand="-" />
          </Location>
          <OMIM>608005</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_022464.5(SIL1):c.947dup (p.Arg317fs)</Name>
      <CanonicalSPDI>NC_000005.10:138951252:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>5q31.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="138951252" stop="138951253" display_start="138951252" display_stop="138951253" variantLength="1" positionVCF="138951252" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="138286941" stop="138286942" display_start="138286941" display_stop="138286942" variantLength="1" positionVCF="138286941" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>R317fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022464.4" sequenceAccession="NM_022464" sequenceVersion="4" change="c.947dup">
            <Expression>NM_022464.4:c.947dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.138951253dup" Assembly="GRCh38">
            <Expression>NC_000005.10:g.138951253dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.9" sequenceAccession="NC_000005" sequenceVersion="9" change="g.138286942dup" Assembly="GRCh37">
            <Expression>NC_000005.9:g.138286942dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008112.2" sequenceAccession="NG_008112" sequenceVersion="2" change="g.252124dup">
            <Expression>NG_008112.2:g.252124dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001037633.2" sequenceAccession="NM_001037633" sequenceVersion="2" change="c.947dup">
            <Expression>NM_001037633.2:c.947dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001032722.1" sequenceAccession="NP_001032722" sequenceVersion="1" change="p.Arg317fs">
            <Expression>NP_001032722.1:p.Arg317fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022464.5" sequenceAccession="NM_022464" sequenceVersion="5" change="c.947dup" MANESelect="true">
            <Expression>NM_022464.5:c.947dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071909.1" sequenceAccession="NP_071909" sequenceVersion="1" change="p.Arg317fs">
            <Expression>NP_071909.1:p.Arg317fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022464.5(SIL1):c.947dup (p.Arg317fs) AND Marinesco-Sjögren syndrome" Accession="RCV000778754" Version="16">
        <ClassifiedConditionList TraitSetID="675">
          <ClassifiedCondition DB="MedGen" ID="C0024814">Marinesco-Sjögren syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-17" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-09-17" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-05-27" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16282977</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24176978</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26733775</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="675" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5454" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Marinesco-Sjogren Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Marinesco-Sjögren syndrome</ElementValue>
                <XRef ID="15820" DB="GeneTests" />
                <XRef ID="Marinesco-Sjogren+syndrome/4478" DB="Genetic Alliance" />
                <XRef ID="80734006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marinesco-Garland Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marinesco-Sjogren Syndrome-Hypergonadotrophic Hypogonadism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marinesco-Sjogren Syndrome-Myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marinesco-Sjogren-Garland Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marinesco-SjÃ¶gren syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MSS</ElementValue>
                <XRef Type="MIM" ID="248800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Marinesco-Sjögren syndrome (MSS) is characterized by cerebellar ataxia with cerebellar atrophy, dysarthria, nystagmus, early-onset (not necessarily congenital) cataracts, myopathy, muscle weakness, and hypotonia. Additional features may include psychomotor delay, hypergonadotropic hypogonadism, short stature, and various skeletal abnormalities. Children with MSS usually present with muscular hypotonia in early infancy; distal and proximal muscular weakness is noticed during the first decade of life. Later, cerebellar findings of truncal ataxia, dysdiadochokinesia, nystagmus, and dysarthria become apparent. Motor function worsens progressively for some years, then stabilizes at an unpredictable age and degree of severity. Cataracts can develop rapidly and typically require lens extraction in the first decade of life. Although many adults have severe disabilities, life span in MSS appears to be near normal.</Attribute>
                <XRef ID="NBK1192" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8341" />
                <XRef ID="8341" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301371</ID>
                <ID Source="BookShelf">NBK1192</ID>
              </Citation>
              <XRef ID="559" DB="Orphanet" />
              <XRef ID="C0024814" DB="MedGen" />
              <XRef ID="MONDO:0009567" DB="MONDO" />
              <XRef Type="MIM" ID="248800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1790189" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="715501" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915118" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26733775</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24176978</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16282977</ID>
          </Citation>
          <Comment>The SIL1 c.947dupT (p.Arg317GlufsTer35) variant results in a frameshift and is predicted to result in premature termination of the protein. The p.Arg317GlufsTer35 has been reported in a total of six individuals with Marinesco-Sjogren syndrome (Senderek et al. 2005; Krieger et al. 2013; Pajusalu et al. 2015). Of these, the variant was found in a homozygous state in two affected cases and in a compound heterozygous state in four affected cases, two of whom were siblings. The p.Arg317GlufsTer35 variant was absent from 160 control subjects and is reported at a frequency of 0.000065 in the European (Non Finnish) population of the Genome Aggregation Database. Based on the evidence and due to the potential impact of frameshift variants, the p.Arg317GlufsTer35 is classified as pathogenic for Marinesco-Sjogren syndrome. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SIL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="5" alternateAllele="CA" referenceAllele="C" start="138286941" stop="138286941" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_022464.4:c.947dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3004559" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_022464.4:c.947dupT|OMIM:248800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001529344" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16282977</ID>
          </Citation>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported in patients with Marinesco-Sjoegren syndrome [PMID 16282977]</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SIL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_022464.4:c.947dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3961292" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="082f4674ffc9b23404cb65c9396f73f8fd6b8b65996332d20f3036eb8c790068|OMIM:248800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002021256" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_022464.4:c.947dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="248800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2378641" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="1285264|MedGen:C0024814" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001213280" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16282977</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24176978</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg317Glufs*35) in the SIL1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 145 amino acid(s) of the SIL1 protein. This variant is present in population databases (rs767943814, gnomAD 0.007%). This premature translational stop signal has been observed in individuals with Marinesco-Sjogren syndrome (PMID: 16282977, 24176978). This variant is also known as 947_948insT, L316fs. ClinVar contains an entry for this variant (Variation ID: 631958). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SIL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000005.9:g.138286941_138286942insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024814" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3004559" TraitType="Disease" MappingType="XRef" MappingValue="248800" MappingRef="OMIM">
        <MedGen CUI="C0024814" Name="Marinesco-Sjögren syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3961292" TraitType="Disease" MappingType="XRef" MappingValue="248800" MappingRef="OMIM">
        <MedGen CUI="C0024814" Name="Marinesco-Sjögren syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2378641" TraitType="Disease" MappingType="XRef" MappingValue="C0024814" MappingRef="MedGen">
        <MedGen CUI="C0024814" Name="Marinesco-Sjögren syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790189" TraitType="Disease" MappingType="XRef" MappingValue="248800" MappingRef="OMIM">
        <MedGen CUI="C0024814" Name="Marinesco-Sjögren syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

